Cargando…
Jin-Wu-Jian-Gu Formulation Attenuates Rheumatoid Arthritis by Inhibiting the IL33-ST2 Signaling Pathway
The present research attempted to investigate the molecular mechanism of Jin-Wu-Jian-Gu Formulation (JWJGF) in inhibiting rheumatoid arthritis (RA) in a pharmacological approach for analysis and experimental validation. First, the potential targets and pathways of JWJGF for RA were predicted by netw...
Autores principales: | Lu, Daomin, Huang, Ying, Ma, Wukai, Chen, Changming, Hou, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794654/ https://www.ncbi.nlm.nih.gov/pubmed/35096114 http://dx.doi.org/10.1155/2022/6821388 |
Ejemplares similares
-
Wu-Teng-Gao External Treatment Improves Th17/Treg Balance in Rheumatoid Arthritis
por: Yao, Xueming, et al.
Publicado: (2022) -
Prediction and Verification of the Major Ingredients and Molecular Targets of Tripterygii Radix Against Rheumatoid Arthritis
por: Ling, Yi, et al.
Publicado: (2021) -
Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
por: Hong, Yeon-Sik, et al.
Publicado: (2011) -
IL-33/ST2-mediated inflammation in macrophages is directly abrogated by IL-10 during rheumatoid arthritis
por: Chen, Si, et al.
Publicado: (2017) -
Hei-Gu-Teng Zhuifenghuoluo Granule Modulates IL-12 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis
por: Zheng, Kang, et al.
Publicado: (2018)